We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




Biomarkers Diagnose Bacteremia in Bone and Joint Infections

By LabMedica International staff writers
Posted on 10 Apr 2013
Several biomarkers routinely measured in clinical laboratories have been studied as tools of detection of bacteremia in childhood infectious diseases.

Blood C-reactive protein (CRP), erythrocyte sedimentation rate (ESR) and white blood cell count (WBC) are widely used laboratory indices in acute childhood bone and joint infection and high serum alkaline phosphatase (ALP) levels are measured in septic conditions. More...


Scientists at the University of Turku (Finland) carried out a prospective and randomized study on 265 children at age 3 months to 15 years with a culture-positive bone or joint infection. Blood samples were collected during the hospitalization, CRP, ESR, and WBC and ALP were measured on admission from all patients, analyzed immediately and the results computerized. The predictive value to detect bacteremia was assessed for each of these four indices.

A cut-off value of 20 mg/L was used for CRP, 20 mm/h for ESR and 15,000/mm3 for WBC. In all, 157 children (59%) showed bacteremia. Staphylococcus aureus was the most common causative agent (75%) followed by Haemophilus influenzae Type B (10%), Streptococcus pyogenes (9%), and Streptococcus pneumoniae (5%).

The initial CRP value was significantly higher in children with bacteremia at 93 mg/L compared with those whose blood cultures remained negative, whose mean CRP value was 77 mg/L. The difference in ESR of bacteremia at 53 mm/H versus nonbacteremia at 47 mm/H was nonsignificant. WBC was significantly lower among bacteraemic patients at 11,900/mm3 compared to13,800/mm3 in those whose blood culture was negative.

The authors concluded that CRP performed better than ESR, WBC or ALP in the detection of bacteremia in acute osteoarticular infections of childhood. CRP is not completely sensitive or specific for bacteremia, but a high CRP value on admission should alert the clinician of the possibility and of the danger of pending sepsis. The article was published in the February 2013 issue of the Journal of Paediatrics and Child Health.

Related Links:

University of Turku




Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Blood-Based Protein Biomarker Solution for Alzheimer's Disease
BG-DTi2000.
Platinum Member
Integrated Biochemical & Immunological System
Biolumi CX Solution X10+C10
Gold Member
POCT RT-qPCR Analyzer
BG-X6
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: NTM are about 200 environmental bacteria found in soil and water that can cause chronic, tuberculosis-like lung infections but are distinct from the Mycobacterium tuberculosis complex (Image Credit: Adobe Stock)

Rapid CRISPR Test Identifies Nontuberculous Mycobacteria Species from Respiratory Samples

Chronic lung infections caused by nontuberculous mycobacteria (NTM) are increasingly recognized but frequently mistaken for tuberculosis, complicating diagnosis and care. These infections may affect as... Read more

Immunology

view channel
Image: Although many people harbor latent Epstein-Barr virus (EBV), growing evidence has linked the virus to MS pathobiology (Image Credit: Adobe Stock)

Blood EBV Activity Biomarkers May Predict Multiple Sclerosis Relapse Months Ahead

Predicting relapse in multiple sclerosis (MS) remains difficult, limiting opportunities for timely intervention and monitoring. Although many people harbor latent Epstein-Barr virus (EBV), growing evidence... Read more

Microbiology

view channel
Image: Graphical Abstract (Jose A. Céspedes, Maria I. Montañez, Isabel M. Jiménez, et al. Magnetic nanoparticles enable clinically relevant in vitro diagnosis of beta-lactam allergy. Materials Today Bio (2026). DOI: 10.1016/j.mtbio.2026.103356)

Magnetic Nanoparticles Enable More Sensitive Beta-Lactam Allergy Testing

Penicillin allergy labels are common in clinical practice, yet many are incorrect and can lead to suboptimal antibiotic choices. Although 8%–25% of people report a penicillin allergy, only 1%–10% are truly... Read more

Pathology

view channel
Image Credit: Adobe Stock

Machine Learning Cytology Tool Improves Cancer Cell Identification

Cytological screening remains central to early cancer detection, but its accuracy depends heavily on expert interpretation of stained cells. Under conventional microscopy, malignant and reactive cells... Read more

Technology

view channel
Image: ADLM recommends that emerging AI tools follow the same professional oversight, quality, validation, and monitoring standards as traditional clinical testing within CLIA’s existing framework (Image Credit: Adobe Stock)

ADLM Calls for CLIA Updates to Support Safe AI Use in Laboratory Medicine

Clinical laboratories increasingly use artificial intelligence to verify, interpret, and report results, but safeguards under the Clinical Laboratory Improvement Amendments (CLIA) were designed in 1992.... Read more

Industry

view channel
Image: The acquisition adds Convergent Genomics’ UroAmp platform and proprietary urinary tumor DNA technology to Veracyte’s portfolio (Photo courtesy of Convergent Genomics)

Veracyte Acquisition Expands Urine-Based Bladder Cancer Monitoring Capabilities

Veracyte, Inc. has acquired Convergent Genomics, expanding its urology diagnostics offerings with the company’s UroAmp platform and proprietary urinary tumor DNA (utDNA) technology. UroAmp has been clinically... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.